Skip to main content

Published locations for FDA approves burosumab to treat X-linked hypophosphatemia

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves burosumab to treat X-linked hypophosphatemia

User login

  • Reset your password
  • /content/fda-approves-burosumab-treat-x-linked-hypophosphatemia
  • /familypracticenews/article/163725/rare-diseases/fda-approves-burosumab-treat-x-linked
  • /internalmedicinenews/article/163725/rare-diseases/fda-approves-burosumab-treat-x-linked
  • /pediatricnews/article/163725/rare-diseases/fda-approves-burosumab-treat-x-linked-hypophosphatemia
  • /rheumatologynews/article/163725/rare-diseases/fda-approves-burosumab-treat-x-linked-hypophosphatemia
  • /clinicalendocrinologynews/article/163725/rare-diseases/fda-approves-burosumab-treat-x-linked
  • /pediatrics/article/163725/rare-diseases/fda-approves-burosumab-treat-x-linked-hypophosphatemia
  • /endocrinology/article/163725/rare-diseases/fda-approves-burosumab-treat-x-linked-hypophosphatemia
  • /rheumatology/article/163725/rare-diseases/fda-approves-burosumab-treat-x-linked-hypophosphatemia
  • /internalmedicine/article/163725/rare-diseases/fda-approves-burosumab-treat-x-linked-hypophosphatemia
  • /familymedicine/article/163725/rare-diseases/fda-approves-burosumab-treat-x-linked-hypophosphatemia